Endodrill (R)- a new instrument for tumor sampling and diagnostics
| Reference number | |
| Coordinator | BibbInstruments AB |
| Funding from Vinnova | SEK 200 000 |
| Project duration | February 2017 - February 2018 |
| Status | Completed |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Competence Enhancement in SME - 2016 |
Important results from the project
Our Project is based on sampling cancer lesions in various organs with an instrument called Endodrill®. We have 7 different instruments for different organs covering cancer sampling of all major cancer types. Our first priority was to build a sterile single-use instrument, which is market standard for endocopic sampling. It was finalised and released in August 2017. Our second aim was to get an instrument for tumor sampling in the respiratory tract.
Expected long term effects
Endodrill® GI Upper is an approved sterile single-use biopsy instrument and was released in August 2017. It has been sold to 10 hospitals in Sweden. Endodrill® for lungs and airways is an approved multiple-use instrument and a study for endoscopic sampling of lung cancer was approved by a Swedish Ethics comiteé in october 2017. We are working on smaller instrument for sampling lymph nodes via endoscopic ultrasound (EBUS) in the airways. A technically advanced project that is ongoing.
Approach and implementation
We have completed a regulatory process of converting Endodrill® GI Upper to a (CE) market standard sterile single-use instrument. Both the instrument and company have been reviewed by a Notified Body and received the certificates to manufacture and sell sterile singel use biopsy instruments. Endodrill® for airways and sampling of lung cancer has been approved as a multiple use instrument. The development of a smaller instrument for sampling of cancer suspicous lymphnodes in the respiratory tract via endoscopic ultrasound has been technically advanced and is ongoing.